Design
Review
Authors
Loading...
Reinforces BNP monitoring in HF; leaves ANP's role as modifiable CV risk factor open for prospective validation.
Key points are not available for this paper at this time.
Rubattu et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: